Clinical-Pathogenetic Role of Connective Tissue Dysplasia Syndrome in Patients with Primary and Recurrent Erysipelas
Purpose: To evaluate the prevalence and the role of undifferentiated connective tissue dysplasia in the pathogenesis of recurrent erysipelas.Materials and Methods: This retrospective study includes patients with primary and recurrent erysipelas who checked up during a period of 24 months. Patient’s...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
State Budget Educational Institute of Higher Professional Education, Rostov State Medical University, Ministry Health of Russian Federation
2012-03-01
|
Series: | Медицинский вестник Юга России |
Subjects: | |
Online Access: | https://www.medicalherald.ru/jour/article/view/1113 |
_version_ | 1811189206162079744 |
---|---|
author | A. B. Ashirova S. N. Orlova |
author_facet | A. B. Ashirova S. N. Orlova |
author_sort | A. B. Ashirova |
collection | DOAJ |
description | Purpose: To evaluate the prevalence and the role of undifferentiated connective tissue dysplasia in the pathogenesis of recurrent erysipelas.Materials and Methods: This retrospective study includes patients with primary and recurrent erysipelas who checked up during a period of 24 months. Patient’s level of free hydroxyproline in blood serum was checked by the colorimetric method of T.P. Kuznetsova.Results: The number of dysembryogenetic stigma in patients with recurrent erysipelas was significantly more than in patients with primary erysipelas. The highest level of hydroxyproline was in patients with recurrent erysipelas.Summary: Patients with erysipelas are characterizes by connective tissue dysplasia. In patients with erysipelas identified changes in the indicators of collagen metabolism, indicating their partial degradation. Increased levels of free hydroxyproline in patients’ blood with erysipelas reflects the destruction of tissue and cellular structures of skin as a result of acute bacterial inflammation. |
first_indexed | 2024-04-11T14:31:58Z |
format | Article |
id | doaj.art-660e0bd8610649ee8e4d3483902df59d |
institution | Directory Open Access Journal |
issn | 2219-8075 2618-7876 |
language | English |
last_indexed | 2024-04-11T14:31:58Z |
publishDate | 2012-03-01 |
publisher | State Budget Educational Institute of Higher Professional Education, Rostov State Medical University, Ministry Health of Russian Federation |
record_format | Article |
series | Медицинский вестник Юга России |
spelling | doaj.art-660e0bd8610649ee8e4d3483902df59d2022-12-22T04:18:31ZengState Budget Educational Institute of Higher Professional Education, Rostov State Medical University, Ministry Health of Russian FederationМедицинский вестник Юга России2219-80752618-78762012-03-01012933599Clinical-Pathogenetic Role of Connective Tissue Dysplasia Syndrome in Patients with Primary and Recurrent ErysipelasA. B. Ashirova0S. N. Orlova1Ivanov State Medical AcademyIvanov State Medical AcademyPurpose: To evaluate the prevalence and the role of undifferentiated connective tissue dysplasia in the pathogenesis of recurrent erysipelas.Materials and Methods: This retrospective study includes patients with primary and recurrent erysipelas who checked up during a period of 24 months. Patient’s level of free hydroxyproline in blood serum was checked by the colorimetric method of T.P. Kuznetsova.Results: The number of dysembryogenetic stigma in patients with recurrent erysipelas was significantly more than in patients with primary erysipelas. The highest level of hydroxyproline was in patients with recurrent erysipelas.Summary: Patients with erysipelas are characterizes by connective tissue dysplasia. In patients with erysipelas identified changes in the indicators of collagen metabolism, indicating their partial degradation. Increased levels of free hydroxyproline in patients’ blood with erysipelas reflects the destruction of tissue and cellular structures of skin as a result of acute bacterial inflammation.https://www.medicalherald.ru/jour/article/view/1113erysipelasdysembryogenetic stigmaconnective tissue dysplasiahydroxyproline |
spellingShingle | A. B. Ashirova S. N. Orlova Clinical-Pathogenetic Role of Connective Tissue Dysplasia Syndrome in Patients with Primary and Recurrent Erysipelas Медицинский вестник Юга России erysipelas dysembryogenetic stigma connective tissue dysplasia hydroxyproline |
title | Clinical-Pathogenetic Role of Connective Tissue Dysplasia Syndrome in Patients with Primary and Recurrent Erysipelas |
title_full | Clinical-Pathogenetic Role of Connective Tissue Dysplasia Syndrome in Patients with Primary and Recurrent Erysipelas |
title_fullStr | Clinical-Pathogenetic Role of Connective Tissue Dysplasia Syndrome in Patients with Primary and Recurrent Erysipelas |
title_full_unstemmed | Clinical-Pathogenetic Role of Connective Tissue Dysplasia Syndrome in Patients with Primary and Recurrent Erysipelas |
title_short | Clinical-Pathogenetic Role of Connective Tissue Dysplasia Syndrome in Patients with Primary and Recurrent Erysipelas |
title_sort | clinical pathogenetic role of connective tissue dysplasia syndrome in patients with primary and recurrent erysipelas |
topic | erysipelas dysembryogenetic stigma connective tissue dysplasia hydroxyproline |
url | https://www.medicalherald.ru/jour/article/view/1113 |
work_keys_str_mv | AT abashirova clinicalpathogeneticroleofconnectivetissuedysplasiasyndromeinpatientswithprimaryandrecurrenterysipelas AT snorlova clinicalpathogeneticroleofconnectivetissuedysplasiasyndromeinpatientswithprimaryandrecurrenterysipelas |